These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 32322871)
1. Reversibly-regulated drug release using poly(tannic acid) fabricated nanocarriers for reduced secondary side effects in tumor therapy. Chen C; Ma T; Tang W; Wang X; Wang Y; Zhuang J; Zhu Y; Wang P Nanoscale Horiz; 2020 Jun; 5(6):986-998. PubMed ID: 32322871 [TBL] [Abstract][Full Text] [Related]
2. pH/H Wang Y; Wang J; Gou K; Kang W; Guo X; Zhu K; Li S; Li H ACS Appl Mater Interfaces; 2021 Aug; 13(30):35397-35409. PubMed ID: 34313104 [TBL] [Abstract][Full Text] [Related]
3. Unsaturated nitrogen-rich polymer poly(l-histidine) gated reversibly switchable mesoporous silica nanoparticles using "graft to" strategy for drug controlled release. Mu S; Liu Y; Wang T; Zhang J; Jiang D; Yu X; Zhang N Acta Biomater; 2017 Nov; 63():150-162. PubMed ID: 28873341 [TBL] [Abstract][Full Text] [Related]
4. pH and Ultrasound Dual-Responsive Polydopamine-Coated Mesoporous Silica Nanoparticles for Controlled Drug Delivery. Li X; Xie C; Xia H; Wang Z Langmuir; 2018 Aug; 34(34):9974-9981. PubMed ID: 30056720 [TBL] [Abstract][Full Text] [Related]
5. Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells. Zhang BB; Chen XJ; Fan XD; Zhu JJ; Wei YH; Zheng HS; Zheng HY; Wang BH; Piao JG; Li FZ Acta Pharmacol Sin; 2021 May; 42(5):832-842. PubMed ID: 33824461 [TBL] [Abstract][Full Text] [Related]
6. Tumor targeting antibody-conjugated nanocarrier with pH/thermo dual-responsive macromolecular film layer for enhanced cancer chemotherapy. Zhuang J; Zhou L; Tang W; Ma T; Li H; Wang X; Chen C; Wang P Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111361. PubMed ID: 33254980 [TBL] [Abstract][Full Text] [Related]
7. Cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment. Liu CM; Chen GB; Chen HH; Zhang JB; Li HZ; Sheng MX; Weng WB; Guo SM Colloids Surf B Biointerfaces; 2019 Mar; 175():477-486. PubMed ID: 30572156 [TBL] [Abstract][Full Text] [Related]
8. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release. Zheng Q; Lin T; Wu H; Guo L; Ye P; Hao Y; Guo Q; Jiang J; Fu F; Chen G Int J Pharm; 2014 Mar; 463(1):22-6. PubMed ID: 24393764 [TBL] [Abstract][Full Text] [Related]
9. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia. Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839 [TBL] [Abstract][Full Text] [Related]
10. Smart MSN-Drug-Delivery System for Tumor Cell Targeting and Tumor Microenvironment Release. Dong JH; Ma Y; Li R; Zhang WT; Zhang MQ; Meng FN; Ding K; Jiang HT; Gong YK ACS Appl Mater Interfaces; 2021 Sep; 13(36):42522-42532. PubMed ID: 34463488 [TBL] [Abstract][Full Text] [Related]
11. Visible Light and pH Responsive Polymer-Coated Mesoporous Silica Nanohybrids for Controlled Release. Wang G; Dong J; Yuan T; Zhang J; Wang L; Wang H Macromol Biosci; 2016 Jul; 16(7):990-4. PubMed ID: 26938147 [TBL] [Abstract][Full Text] [Related]
12. Acidity and Glutathione Dual-Responsive Polydopamine-Coated Organic-Inorganic Hybrid Hollow Mesoporous Silica Nanoparticles for Controlled Drug Delivery. Chen Q; Chen Y; Zhang W; Huang Q; Hu M; Peng D; Peng C; Wang L; Chen W ChemMedChem; 2020 Oct; 15(20):1940-1946. PubMed ID: 32762008 [TBL] [Abstract][Full Text] [Related]
13. Polymer-Coated Hollow Mesoporous Silica Nanoparticles for Triple-Responsive Drug Delivery. Zhang Y; Ang CY; Li M; Tan SY; Qu Q; Luo Z; Zhao Y ACS Appl Mater Interfaces; 2015 Aug; 7(32):18179-87. PubMed ID: 26221866 [TBL] [Abstract][Full Text] [Related]
14. A novel high drug loading mussel-inspired polydopamine hybrid nanoparticle as a pH-sensitive vehicle for drug delivery. Hou J; Guo C; Shi Y; Liu E; Dong W; Yu B; Liu S; Gong J Int J Pharm; 2017 Nov; 533(1):73-83. PubMed ID: 28943209 [TBL] [Abstract][Full Text] [Related]
15. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery. Zhang Q; Zhao H; Li D; Liu L; Du S Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088 [TBL] [Abstract][Full Text] [Related]
16. Improving anti-cancer drug delivery performance of magnetic mesoporous silica nanocarriers for more efficient colorectal cancer therapy. Iranpour S; Bahrami AR; Nekooei S; Sh Saljooghi A; Matin MM J Nanobiotechnology; 2021 Oct; 19(1):314. PubMed ID: 34641857 [TBL] [Abstract][Full Text] [Related]
17. pH-triggered charge-reversal and redox-sensitive drug-release polymer micelles codeliver doxorubicin and triptolide for prostate tumor therapy. Xu C; Song RJ; Lu P; Chen JC; Zhou YQ; Shen G; Jiang MJ; Zhang W Int J Nanomedicine; 2018; 13():7229-7249. PubMed ID: 30510415 [TBL] [Abstract][Full Text] [Related]
18. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles. Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911 [TBL] [Abstract][Full Text] [Related]
19. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release. Hu X; Wang Y; Peng B Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568 [TBL] [Abstract][Full Text] [Related]
20. Surface modification of doxorubicin-loaded nanoparticles based on polydopamine with pH-sensitive property for tumor targeting therapy. Bi D; Zhao L; Yu R; Li H; Guo Y; Wang X; Han M Drug Deliv; 2018 Nov; 25(1):564-575. PubMed ID: 29457518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]